The Core Technology Powering U: The Mind Company.
The deep-dive. Here you'll find the mechanisms, the waveform science, the electrode placement logic, and the safety data behind amplitude-modulated transcranial pulsed current stimulation. The core technology powering U: The Mind Company.
What is am-tPRNS?
Amplitude-modulated transcranial pulsed current stimulation (am-tPRNS) is a form of non-invasive brain stimulation that delivers precisely controlled electrical pulses through the scalp to targeted brain regions. Unlike traditional transcranial direct current stimulation (tDCS), which applies a constant current to a single hemisphere, am-tPRNS modulates the amplitude of the signal, varying the intensity in carefully designed patterns across BOTH HEMISPHERES. This promotes interhemispheric communication, which is more effective for neuroplasticity than one-sided stimulation.
This modulation is the key innovation. By varying the stimulation pattern rather than applying a static signal, am-tPRNS engages the brain's natural oscillatory rhythms more effectively, promoting activity-dependent neuroplasticity. The brain's ability to reorganize and strengthen its connections in response to stimulation.
The analogy is exercise. Just as varying your workout routine produces better fitness results than doing the same thing every day, varying the stimulation pattern produces more robust neural adaptation than constant stimulation.
How am-tPRNS Works
The device generates a pulsed current whose amplitude is continuously modulated, creating complex temporal patterns that mirror the brain's own oscillatory rhythms. Electrode placement follows standardized configurations targeting specific brain networks: motor cortex for Parkinson's, prefrontal and temporal regions for Alzheimer's, and the frontoparietal network for cognitive wellness. This modulation promotes activity-dependent neuroplasticity through LTP-like effects, network rebalancing, and cumulative adaptation that builds over repeated sessions. am-tPRNS operates at current densities well below tissue damage thresholds. Across 250+ people studied and over 2,000,000 treatment minutes, no serious adverse events have been reported. The most common side effect is mild, transient tingling at the electrode site.
am-tPRNS vs. other stimulation technologies
am-tPRNS (U)
• Variable amplitude pattern
• Bilateral hemisphere targeting
• LTP-like effects
• Better neural adaptation
tDCS (Competitors)
• Constant current
• Single hemisphere
• Quick brain adaptation
• Weaker long-term effects
TMS (Clinical)
• Magnetic pulses
• Clinic-only
• High cost
• Strong evidence base
DBS (Surgery)
• Implanted electrodes
• Surgery required
• Highest efficacy
• Significant risks
Want the full scientific evidence?
Our research whitepaper contains more information about brain stimulation, study designs, data tables, and statistical analyses.